Enliven Therapeutics, Inc. · NASDAQ:ELVN
Derynck Mika K sold 158,795 Enliven Therapeutics, Inc. shares (Form 4)
Traded Aug 4, 2026 · Filed Aug 6, 2026
On Aug 4, 2026, Derynck Mika K (Director) sold 158,795 Enliven Therapeutics, Inc. shares at US$60.21 for US$9.56M under a trading plan, leaving 0 shares. Filed Aug 6, 2026 (Form 4).
- Sold
- 158,795 shares
- Price
- US$60.21
- Value
- US$9.56M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Common Stock | Option exercise | 87,373 | US$2.48 | 87,373 | Direct |
| Aug 4, 2026 | Common Stock | Option exercise | 27,567 | US$25.28 | 114,940 | Direct |
| Aug 4, 2026 | Common Stock | Option exercise | 23,364 | US$14.85 | 138,304 | Direct |
| Aug 4, 2026 | Common Stock | Option exercise | 20,491 | US$22.47 | 158,795 | Direct |
| Aug 4, 2026 | Common Stock | Sale | 158,795 | US$60.21 | 0 | Direct |